David Nassim: Keep Ibogaine Sustainable

David Nassim is the co-director of Blessings of the Forest (BOTF), an organization that supports environmental and traditionalist associations, Indigenous communities and administrative authorities committed to the preservation and sustainable development of Gabon’s natural and cultural heritage – including the preservation of iboga, the West African plant from which ibogaine is derived.

‍What we discuss:

The work that BOTF does and its role in the iboga supply chain

The Nagoya Protocol: What it is, and how it informs the protection of the iboga plant and the communities that use it

The unseen challenges of working closely with a large number of different organizations, associations, and communities

The role of iboga in David’s life, and the different Bwiti traditions that he has worked with

How iboga is viewed globally: the different interpretations and understandings in the United States and Gabon

What is at the root of the reverence Gabonese people have for iboga?

The implications of Western interest, namely the Kentucky Opioid Abatement Advisory Program and its interest in ibogaine

What questions to ask when determining how a practitioner has obtained iboga/ibogaine

Is there any overlap between what you’ve learned from Chinese Medicine, and from your work with iboga?

Why it’s important:

In North America, ibogaine is a compound that most people associate with opioid use disorder, but in West Africa, specifically in Gabon, ibogaine is just one part of a much greater whole. In this episode, David Nassim explains in great detail the implications of increased global interest in the iboga plant for the Bwiti communities that depend on it. By leaning on the Nagoya Protocol on Access and Benefit-sharing, Blessings of the Forest is working to protect and preserve iboga while building meaningful relationships directly with communities that require support. David’s insights and understanding bring the issue of reciprocity into sharp focus, and challenge us to consider the global implications of pursuing a treatment like ibogaine.